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Abstract
Background: Stroke is a leading cause of disability among adults worldwide. Evidence suggests
that increased duration of exercise therapy following stroke has a positive impact on functional
outcome following stroke. The main objective of this randomised controlled trial is to evaluate the
impact of additional family assisted exercise therapy in people with acute stroke.
Methods/Design: A prospective multi-centre single blind randomised controlled trial will be
conducted. Forty patients with acute stroke will be randomised into either an experimental or
control group. The experimental group will receive routine therapy and additional lower limb
exercise therapy in the form of family assisted exercises. The control group will receive routine
therapy with no additional formal input from their family members. Participants will be assessed at
baseline, post intervention and followed up at three months using a series of standardised outcome
measures. A secondary aim of the project is to evaluate the impact of the family mediated exercise
programme on the person with stroke and the individual(s) assisting in the delivery of exercises
using a qualitative methodology. The study has gained ethical approval from the Research Ethics
Committees of each of the clinical sites involved in the study.
Discussion: This study will evaluate a structured programme of exercises that can be delivered to
people with stroke by their 'family members/friends'. Given that the progressive increase in the
population of older people is likely to lead to an increased prevalence of stroke in the future, it is
important to reduce the burden of this illness on the individual, the family and society. Family
mediated exercises can maximise the carry over outside formal physiotherapy sessions, giving
patients the opportunity for informal practice.
Trial Registration: The protocol for this study is registered with the US NIH Clinical trials
registry (NCT00666744)
Background
Stroke is a leading cause of disability among adults in
developed countries [1]. The progressive increase in the
population of older people is likely to lead to an increased
prevalence of stroke in the future [2]. In contrast to coro-
nary heart disease and cancer, the burden of stroke lies
with long-term disability as opposed to death. Any reha-
bilitation intervention that can speed recovery and reduce
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long-term disability would have a major impact on both
the individual and the social burden of this illness. One
major component of rehabilitation after a stroke is exer-
cise therapy which serves to minimise the effects of the
brain cell damage and optimise re-learning [3-5]. In this
manuscript, we describe a novel protocol to increase exer-
cise therapy time following stroke by involving the family
members in the delivery of additional exercises to people
with stroke.
Physiotherapists have traditionally been the mediators of
exercise therapy post-stroke. Over the years different phys-
iotherapy approaches have been advocated to promote
motor recovery, including the methods of Bobath,
Brunnstrom, Rood and the Proprioceptive Neuromuscu-
lar Facilitation (PNF) technique [6,7]. All of these therapy
approaches are exercise based and there is evidence that
physiotherapy and occupational therapy, using a mix of
components from these different approaches, is signifi-
cantly more effective than no treatment or placebo control
in the recovery of functional independence following
stroke [6]. Nonetheless, it has been suggested that the
duration of exercise therapy that is delivered post stroke is,
at best, 'homeopathic' [8].
Evidence from two systematic reviews [9,10] has sug-
gested that a more intensive exercise therapy input is asso-
ciated with enhanced improvement of the performance of
functional activities after stroke, although the exact dose
of practice required for significant functional improve-
ments to take place is lacking. A later meta-analysis [11]
also demonstrated that additional exercise therapy has a
positive outcome on gait speed and activities of daily liv-
ing. However this meta-analysis included studies where
no formal exercise therapy was documented in the 'con-
trol' group [12-15]. The authors completed a systematic
review and meta-analysis [17] that examined the effects of
additional exercise therapy time by comparing ran-
domised controlled trials that provided 'routine' therapy
to the control group versus studies that provided 'routine'
therapy together with 'additional' exercise therapy to the
intervention group. The findings demonstrated that
increased duration of exercise therapy time had a small
but positive effect on activities of daily living as measured
by the Barthel Index. Although the meta-analysis of the
lower extremity outcome measures lacked significant
findings, very few studies were included in the analysis
and the results were supportive of the hypothesis that
more exercise therapy improved gait speed and lower
limb impairment in people with stroke. The review also
highlighted the need for further randomised controlled
trials with large sample sizes to evaluate the effectiveness
of increased duration of exercise therapy on lower extrem-
ity outcome [17].
While the available evidence suggests that more physio-
therapy is better, additional therapy is expensive and not
routinely funded routinely by the National Health Service
in the UK or by health insurance companies [18]. There-
fore, research is now focusing on novel ways of increasing
the duration of exercise therapy that occurs following
stroke with minimal use of resources [8]. One suggestion
has been that 'physiotherapists need to develop strategies
whereby patients and caregivers take full responsibility for
the bulk of therapy – for instance, training of balance,
strength and endurance, repetition of simple tasks, group
therapy, fitness-related training and family involvement'
[19]. To date no randomised controlled trial (RCT) has
evaluated the delivery of exercise by people who are not
health care workers, although in a RCT by Lincoln, Parry
and Vass [20], both qualified physiotherapists and physi-
otherapy assistants delivered two different forms of addi-
tional exercise therapy and no differences were noted
between the groups. The following paper reports on the
design of an evidence-based, user informed and centred
RCT to evaluate the impact of increased duration of family
mediated exercise (FAME) therapy in people with stroke.
Background Work
A full systematic review and meta-analysis of previous
work in this area was completed and has been accepted for
publication [17]. The meta-analysis supported the theory
that additional exercise therapy has a positive impact on
outcome following stroke. However, the systematic
review highlighted issues with patient compliance, partic-
ular patient subgroups, type of therapy, number of addi-
tional minutes of exercise therapy delivered to patients
and long terms benefits of additional exercise therapy.
These issues were considered in the development of the
FAME RCT.
In addition, three user surveys were conducted to explore
the views of potential participants in the FAME pro-
gramme i.e. the individual with stroke, 'family members/
friends' of people with stroke and the physiotherapists. A
self-report questionnaire was administered to 100 'family
members/friends' and 75 people with stroke. Two focus
groups were conducted with ten expert physiotherapists
working in the area of stroke rehabilitation. The results of
the three user surveys supported and informed the devel-
opment of the FAME trial. Family members of people with
stroke indicated that they were willing to participate in the
delivery of unsupervised exercises in the hospital and the
home setting (n = 91). Furthermore, this method was also
acceptable to people with stroke (n = 65) as an adjunct to
routine physiotherapy. Physiotherapists highlighted a
number of factors that influenced participation in physi-
cal therapy such level of interest and motivation of the
family (n = 5), availability (n = 3) and importance of edu-
cation (n = 2). 'Family members/friends' also identifiedBMC Neurology 2008, 8:22 http://www.biomedcentral.com/1471-2377/8/22
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reasons that would also limit participation such as work
commitments (n = 24), lack of confidence (n = 20) and
unsuitable treatment times (n = 13). The results of these
user surveys are described elsewhere [21-24].
Aims and Objectives of the Study
The aim of the study is to evaluate the functional recovery
in two groups of primary stroke patients presenting with
moderate/severe disability over a six month period
through the implementation of a randomised controlled
trial. The first group or the experimental group will receive
routine therapy and additional lower limb exercise ther-
apy in the form of family assisted exercises. The second
group or the control group will receive routine therapy
with no additional formal input from their family mem-
bers. A secondary aim of the project is to evaluate the
impact of the FAME programme on the person with stroke
and the individual(s) assisting in the delivery of exercises.
Ethical Considerations
The study has obtained ethical approval from four clinical
sites: Saint Vincent's University Hospital Ethics and Med-
ical Research Committee (Ref 9/5/07), Saint Colmcilles
Hospital (Ref 9/5/07), the Mater Misercordiae University
Hospital Research Ethics Committee (Ref 1/378/1138)
and Beaumont Hospital Ethics (Medical Research) Com-
mittee (Ref 08/19).
Methods
Study Design
A prospective single-blind randomised controlled trial
will be conducted. Forty subjects will be randomised into
either an experimental group or a control group using
sealed, computer generated random numbers. The pro-
gression from screening and enrollment to randomisation
is illustrated in Figure legend 1.
Intervention
Members of the control group and the experimental group
will receive 'routine' physiotherapy for the duration of the
trial, which will be delivered by the physiotherapy staff in
the hospital. In addition, participants in the experimental
group will be given individualised FAME programmes to
be conducted at the bedside with his/her nominated 'fam-
ily member/friend'. Each programme will consist of train-
ing the 'family member/friend' with the skills necessary to
carry out the exercise-training programme with the person
with stroke on a weekly basis. This specialised interven-
tion will be designed and delivered by the research physi-
otherapist (RG). Exercises will be designed appropriate to
the participants' ability. The emphasis of the lower limb
exercise intervention will be on achieving stability and
improving gait velocity and lower limb strength, based on
patterns derived from findings reported in a systematic
review of 151 intervention studies on stroke rehabilita-
tion [25].
Based on the output from the systematic reviews and
meta-analyses [11,17], it was determined that the trial
would continue for eight weeks with an expectation that
at least 1200 additional minutes of family mediated exer-
cise therapy will be delivered over this time period. Each
FAME session is expected to last 35 minutes and will be
conducted on a daily basis. The nominated 'family mem-
ber/friend' will be requested to fill out a daily exercise
diary following completion of the prescribed exercises to
document compliance.
Blinding
An independent physiotherapist blinded to group alloca-
tion will assess all participants using the battery of out-
come assessments on entry to the study, on completion of
the eight-week trial and finally at the three month follow-
up stage.
Outcome
The primary outcome measure used in this trial will be the
lower extremity section of Fugl Meyer (FM) Assessment
[26]. The FM is considered by many in the area of stroke
rehabilitation to be one of the most inclusive quantitative
measures of sensorimotor impairment following stroke
and its use has gained international acceptance as a feasi-
ble and appropriate clinical and research tool for evaluat-
ing changes in motor impairment following stroke [27].
Excellent intra-rater and inter-rater reliability and con-
struct validity have been demonstrated [28,29].
A series of secondary outcome measures will also be used
to evaluate participants' recovery including the Motor
Assessment Scale [30], the Berg Balance Scale [31], the Six
Minute Walk Test [32] the Barthel Index [33], the Reinte-
gration to Normal Living Index [34] and the Nottingham
Extended Activities of Daily Living Index [35].
The Caregiver Strain Index [36], a 13-item self-report
measure designed to measure strain relating to care provi-
sion, will be administered to the nominated 'family mem-
ber/friend' of the person with stroke. In addition, a semi-
structured interview will take place with each participant
and their nominated 'family member/friend' individually,
in relation to their experience of the exercise therapy pro-
gramme. A physiotherapist unknown to the participant
will conduct interviews. All interviews will be audio
recorded.
Participant Selection
Potential participants will be recruited from four acute
hospitals. A register of all stroke patients admitted to these
hospitals will be sent to the research physiotherapist on aBMC Neurology 2008, 8:22 http://www.biomedcentral.com/1471-2377/8/22
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Outline of FAME study design Figure 1
Outline of FAME study design.
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weekly basis. Those patients who are survivors at two
weeks following the onset of stroke will be assessed using
the Orpington Prognostic Scale. The Orpington Prognos-
tic Scale was developed by Kalra and Crome [37] in order
to stratify stroke patients according to severity of stroke.
The Orpington Prognostic Score (OPS) is a clinically
derived score that incorporates measures of cognitive
impairment, motor deficit, balance and proprioception.
The score ranges from 1.6 (best prognosis/lowest level of
disability) to 6.8 (worst prognosis/highest level of disabil-
ity). It has its highest predictive power of levels of depend-
ence when assessed at two weeks following the onset of
stroke [37-39]. Only patients who achieve a score from
3.2 – 5.2 on the OPS at two weeks post stroke will be
recruited to this study. This cohort of patients has been
described as the 'middle group' of stroke patients and con-
sists of people presenting with a moderate/severe deficit
following stroke [38]. It has been suggested that outcome
in this band of patients depends on extrinsic factors such
as the intensity and quality of rehabilitation, family sup-
port, the personality and motivation of the patient and
the availability of statutory and voluntary support systems
in the community [38]. The scale has been validated for
both an elderly and an Irish stroke population [37,40].
The test-retest and inter-rater reliability of the OPS has
also been established [40].
Inclusion/Exclusion Criteria
Patients will be admitted to the study if they present with
a formal diagnosis of first unilateral stroke, are over 18
years, are willing to give informed consent and have 'fam-
ily members/friends' willing to participate in their
assigned physiotherapy intervention programme. Patients
will be excluded if they present with hemiplegia of a non-
vascular origin, are discharged from hospital at baseline
less than two weeks following stroke, have an OPS score
of less than 3.2 or greater than 5.2 at two weeks following
stroke onset, have a pre-existing neurological disorder
resulting in a motor deficit in addition to that resulting
from the stroke, present with any lower extremity ortho-
paedic condition such as recent fractured femur or ampu-
tation or have receptive/expressive dysphasia.
'Family members/friends' will be included if they have
been nominated by the person with stroke to assist him/
her in the performance of their prescribed exercises and
are medically stable and physically able to assist in the
delivery of exercises to the person with stroke. Suitability
will be determined in liaison with the physiotherapist in
charge on the patients' routine care. Family members/
friends' will also be required to give informed written con-
sent agreeing to help their 'family member/friend' with
stroke in the performance of his/her prescribed exercises.
Recruitment
The research physiotherapist (RG) will be responsible for
assessing eligibility for inclusion into the study and also
for obtaining informed consent from the patient and his/
her 'family member/friend'. Following identification of
suitable participants i.e. people with stroke and their
nominated family member/friend, the aims of the project,
including the role of the participant and his/her "family
member/friend" in the FAME programme, will be out-
lined and any questions answered by RG. The person with
the stroke and his/her 'family member/friend' will each
receive a separate information brochure in advance of
being asked to give written informed consent agreeing to
participate. Participants will have seven days between
receipt of the information brochure and being requested
to give written permission. Following the 7-day interval,
RG will answer or clarify any further questions that arise
and both the person with stroke and his/her 'family mem-
ber/friend' will be requested to sign a consent form in the
presence of each other. If either the patient or his/her
'family member/friend' are unwilling to give written con-
sent, they will be excluded from the study. If they decide
to partake in the study, participants will be advised that
they can withdraw from the study at any time and that the
study will not interfere with their routine rehabilitation
programme. Participants will be allocated a reference
code. Names and other details that may identify the par-
ticipants will be removed.
Randomisation
To minimise the possibility of recruitment bias, a person
independent of the recruitment process will complete ran-
dom group allocation. Computer generated random
numbers will be kept in pre-sealed envelopes in a locked
drawer. Allocation will be revealed after recruitment by a
telephone call from RG to an independent person, who
will open the next envelope in the sequence and give the
randomisation information to RG. Each envelope will
only be opened on enrollment of an eligible participant.
After allocation has been revealed, the appropriate inter-
vention will be organised by RG.
Power
Sample size is based on a power analysis. A sample size
calculation was performed for the primary outcome vari-
able, which is the lower extremity section of the Fugl-
Meyer (FM). For the FM lower extremity, a change of
greater than five points reflects a change greater than
measurement error [42]. Power calculations indicate that
a total of 40 participants are needed in order to detect with
80% power a difference of 20% between the groups at a
significance level of 5%. It is anticipated that it will take
18–24 months to recruit the required number of partici-
pants.BMC Neurology 2008, 8:22 http://www.biomedcentral.com/1471-2377/8/22
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Analysis
All data will be collected on paper and the records will be
stored by registration number in a secure cabinet. Ano-
nymised data will be transferred to a computer database
and secured using a password. An independent researcher
will cross check all entries. Appropriate statistical tests will
be carried out on the data using MINITAB Release 13.1.
The statistical analyses will be performed according to the
'intention to treat' principle and participants will be ana-
lysed in the group to which they were randomly assigned.
Participants who withdraw from the experimental group
but allow further data collection will have data collected.
A 'last measurement carried forward' method is used to
predict outcome in dropouts [43].
The purpose of the statistical analysis is to test the hypoth-
esis that there will be a clinically significant difference in
functional recovery between participants in the control
group and the experimental group from baseline to post-
intervention assessment. Firstly, the baseline scores of the
participants' demographic, primary and secondary out-
comes will be compared in the two groups. If necessary,
adjustments for baseline variables will be made using
analysis of covariance. Analyses will be carried out to
examine the difference between the groups with respect to
the change in the lower extremity FM test score from base-
line to post-intervention assessment. Secondary outcomes
will be compared between the two groups using Student's
t-test or the Wilcoxon rank sum test for ordinal data.
Descriptive statistics will also be used to represent demo-
graphic data.
All interviews will be tape recorded, transcribed and
examined in terms of themes according to the method
devised by Miles and Hubberman [44]. The responses
from all participants to each question will be transferred
to Microsoft Excel for examination. Following an exami-
nation of the responses to each question, a coding system
will be developed in order to facilitate the identification of
recurrent responses. Three researchers will be provided
with the responses to all of the questions in an unencoded
format; thereafter they will independently code the
responses sequentially using the predefined codes. All
coding disagreements will be resolved through discus-
sion.
Discussion
The concept of family mediated exercise therapy is not a
new phenomenon. It is common practice in rehabilitation
of children with neurological impairments [45]. While it
cannot be denied that the sudden and profound effects of
stroke on family roles and functioning create stress for the
stroke survivor and their families, the available evidence
suggests that carers and families want information and
want to be more fully involved in their rehabilitation
[46,47]. It is also evident that more therapy is of benefit to
people with stroke and the aim of this RCT is to maximise
motor recovery by allowing the patient to practice activi-
ties with his/her family outside of the routine treatment
hours. The qualitative data will allow the researchers a
deeper insight into the impact of the programme of the
patient and his/her family. Only by establishing evidence-
based interventions, such as the one outlined in this pro-
tocol, can we strive to reduce the impact of this illness on
the individual, the family and society.
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